Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
A variety of approaches have been used to alleviate symptoms in postural tachycardia syndrome (POTS). Drugs reported to be of benefit include midodrine, propranolol, clonidine, and phenobarbital. Other measures used include volume expansion and physical countermaneuvers. These treatments may influence pathophysiologic mechanisms of POTS such as alpha-receptor dysfunction, beta-receptor supersensitivity, venous pooling, and brainstem center dysfunction. The authors prospectively studied hemodynamic indices and symptom scores in patients with POTS who were acutely treated with a variety of interventions. Twenty-one subjects who met the criteria for POTS were studied (20 women, 1 man; mean age, 28.7 +/- 6.8 y; age range, 14-39 y). Patients were studied with a 5-minute head-up tilt protocol, ECG monitoring, and noninvasive beat-to-beat blood pressure monitoring, all before and after the administration of an intervention (intravenous saline, midodrine, propranolol, clonidine, or phenobarbital). The hemodynamic indices studied were heart rate (ECG) and systolic, mean, and diastolic blood pressure. Patients used a balanced verbal scale to record any change in their symptoms between the tilts. Symptom scores improved significantly after the patients received midodrine and saline. Midodrine and propranolol reduced the resting heart rate response to tilt (p <0.005) and the immediate and 5-minute heart rate responses to tilt (p <0.002). Clonidine accentuated the immediate decrease in bl…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Expert centers report anecdotally that 1 L of normal saline infused over 1 hour decreases orthostatic tachycardia and improves symptoms for several hours to 2 days.40,41”
Citations
Cites
Idiopathic postural orthostatic tachycardia syndrome: An attenuated form of acute pandysautonomia?
Schondorf, R., & Low, P. A. (1993) · Neurology · doi:10.1212/wnl.43.1_part_1.132 · Cited by 548
Self-citationA double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension
Wright, R. A., Kaufmann, H. C., Perera, R., Opfer-Gehrking, T. L., McElligott, M. A., Sheng, K. N., & Low, P. A. (1998) · Neurology · doi:10.1212/wnl.51.1.120 · Cited by 331 · cited 2×
“A 1-L volume expansion in the form of intravenous normal saline improved tilt tolerance, evaluated using a balanced validated scale [10], and reduced resting heart rate and orthostatic heart rate.”
MethodSelf-citationEffects of volume loading and pressor agents in idiopathic orthostatic tachycardia
Jacob, G., Shannon, J. R., Black, B., Biaggioni, I., Mosqueda-Garcia, R., Robertson, R. M., & Robertson, D. (1997) · Circulation · doi:10.1161/01.cir.96.2.575 · Cited by 206 · cited 2×
“These findings are in overall agreement with a recent publication [1] reporting that the main change was in heart rate.”
BackgroundResultClinical autonomic disorders : evaluation and management
Low, P. A. (1997) · Cited by 203
Self-citationClinical Autonomic Disorders: Evaluation and Management
Streeten, D. H. P. (1998) · Mayo Clinic Proceedings · doi:10.4065/73.11.1126-a · Cited by 168
FOUAD, F. M., TADENA-THOME, L., BRAVO, E. L., & TARAZI, R. C. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-3-298 · Cited by 154 · cited 2×
“Proposed mechanisms include hypovolemia [1-3], venous pooling [4,5], ~x-adrenergic receptor dysfunction [6], [3-adrenergic receptor supersensitivity [7], altered sympathetic-parasympathetic balance [8], and brainstem dysregulation [7].”
BackgroundResultLow, P. A., Opfer-Gehrking, T. L., Textor, S. C., Schondorf, R., Suarez, G. A., Fealey, R. D., & Camilleri, M. (1994) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(94)90008-6 · Cited by 105
Self-citationRosen, S. G., & Cryer, P. E. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90559-9 · Cited by 104 · cited 2×
“Proposed mechanisms include hypovolemia [1-3], venous pooling [4,5], ~x-adrenergic receptor dysfunction [6], [3-adrenergic receptor supersensitivity [7], altered sympathetic-parasympathetic balance [8], and brainstem dysregulation [7].”
BackgroundResultPostural Tachycardia Syndrome: A Concise and Practical Guide to Management and Associated Conditions
(2020) · Springer eBooks · doi:10.1007/978-3-030-54165-1 · Cited by 96
Orthostatic Disorders of the Circulation
Streeten, D. H. P. (1987) · Springer eBooks · doi:10.1007/978-1-4684-8962-0 · Cited by 70
Research works printed but not linked: 3
- Low PA, Opfer-Gehrking TL, Benarroch EE, Shen W-K. Management strategy for the postural tachycardia syndrome [abstract].Ann Neurol 1994; 36:318.
- Low PA, Allison T, McPhee B, Wiseman G, Opfer-Gehrking TL, Spies JM, et al. Efficacy of resistance training in improving orthostatic tolerance in POTS [abstract].Clin Auton Res 1998; 8:279.
- Jacob G, Wathen MS, Robertson RM, Costa F, Shannon JR, Biaggioni I, et al. The function of systemic and local cardiovascular adrenoreceptors in orthostatic intolerance: evidence of partial dysautonomia [abstract].Clin Auton Res 1996; 6:296–297.
Cited by
Sheldon, R. S., Grubb, B. P., Olshansky, B., Shen, W.-K., Calkins, H., Brignole, M., Raj, S. R., Krahn, A. D., Morillo, C. A., Stewart, J. M., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.029 · Cited by 1,013
“Expert centers report anecdotally that 1 L of normal saline infused over 1 hour decreases orthostatic tachycardia and improves symptoms for several hours to 2 days.(40,41) Although it has not yet been assessed in a clinical trial, this approach is recommended as rescue therapy for patients who are clinically decompens…”
BackgroundPostural orthostatic tachycardia syndrome: the Mayo clinic experience
Thieben, M. J., Sandroni, P., Sletten, D. M., Benrud-Larson, L. M., Fealey, R. D., Vernino, S., Low, P. A., Lennon, V. A., & Shen, W.-K. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61027-6 · Cited by 516
Self-citationPostural tachycardia syndrome: a heterogeneous and multifactorial disorder
Benarroch, E. E. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.08.013 · Cited by 370
Postural tachycardia syndrome (POTS)
LOW, P. A., SANDRONI, P., JOYNER, M., & SHEN, W. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01407.x · Cited by 358
Self-citationPostural tachycardia syndrome—current experience and concepts
Mathias, C. J., Low, D. A., Iodice, V., Owens, A. P., Kirbis, M., & Grahame, R. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.187 · Cited by 251
Postural orthostatic tachycardia syndrome as a sequela of COVID-19
Ormiston, C. K., Świątkiewicz, I., & Taub, P. R. (2022) · Heart Rhythm · doi:10.1016/j.hrthm.2022.07.014 · Cited by 163
What is brain fog? An evaluation of the symptom in postural tachycardia syndrome
Ross, A. J., Medow, M. S., Rowe, P. C., & Stewart, J. M. (2013) · Clinical Autonomic Research · doi:10.1007/s10286-013-0212-z · Cited by 141
“Previous studies have shown that acute IV saline reduces tachycardia and symptoms in POTS [19, 20].”
BackgroundPostural Orthostatic Tachycardia Syndrome (POTS): A critical assessment
Olshansky, B., Cannom, D. S., Fedorowski, A., Stewart, J. M., Gibbons, C. H., Sutton, R., Shen, W.-K., Muldowney, J. A. S., Chung, T., Feigofsky, S., et al. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.03.010 · Cited by 116
Pharmacotherapy for postural tachycardia syndrome
Miller, A. J., & Raj, S. R. (2018) · Autonomic Neuroscience · doi:10.1016/j.autneu.2018.04.008 · Cited by 91
Postural Orthostatic Tachycardia Syndrome: Prevalence, Pathophysiology, and Management
Zadourian, A., Doherty, T. A., Swiatkiewicz, I., & Taub, P. R. (2018) · Drugs · doi:10.1007/s40265-018-0931-5 · Cited by 90
“Although it is reasonable to treat POTS patients with short-term clinical decompensations with rescue IV infusions of saline (up to 2 L), regular saline IV infusions are not recommended for POTS patients in the absence of evidence [1, 70, 71].”
BackgroundRoss, A. J., Ocon, A. J., Medow, M. S., & Stewart, J. M. (2014) · Clinical Science · doi:10.1042/cs20130222 · Cited by 78
“An occlusion cuff (Hokanson) was placed around the thigh approximately 10 cm above a strain gauge (Hokanson), which was placed at the calf, to allow for measurement of Q̇calf via venous occlusion strain gauge plethysmography as described previously [6,14].”
MethodA review of postural orthostatic tachycardia syndrome
Carew, S., Connor, M. O., Cooke, J., Conway, R., Sheehy, C., Costelloe, A., & Lyons, D. (2008) · Europace · doi:10.1093/europace/eun324 · Cited by 73
“It promotes sodium and fluid retention and improves sensitivity of peripheral alpha-adrenergic receptors.49 Fludrocortisone or bisoprolol or both improved the symptoms and haemodynamic abnormalities in a group of 11 patients with POTS.50 Side effects include hypokalaemia, hypomagnesaemia, hypertension, and peripheral…”
BackgroundInfluentialStewart, J. M., Munoz, J., & Weldon, A. (2002) · Circulation · doi:10.1161/01.cir.0000040999.00692.f3 · Cited by 71
Postural tachycardia syndrome: current perspectives
Wells, R., Spurrier, A. J., Linz, D., Gallagher, C., Mahajan, R., Sanders, P., Page, A., & Lau, D. H. (2017) · Vascular Health and Risk Management · doi:10.2147/vhrm.s127393 · Cited by 69
“While positive response to acute intervention with intravenous fluids and midodrine has been demonstrated during a 5-minute tilt test, this has yet to be correlated with long-term response.(34)”
BackgroundCOVID-19 Induced Postural Orthostatic Tachycardia Syndrome (POTS): A Review
Mallick, D. C., Goyal, L., Chourasia, P. K., Zapata, M. R., Yashi, K., & Surani, S. (2023) · Cureus · doi:10.7759/cureus.36955 · Cited by 83
“For patients who cannot tolerate oral fluid, an IV bolus of 1 to 2 L of normal saline can be used as a shortterm strategy for up to two days [66-68].”
MethodEfficacy of Therapies for Postural Tachycardia Syndrome: A Systematic Review and Meta-analysis
Wells, R., Elliott, A. D., Mahajan, R., Page, A., Iodice, V., Sanders, P., & Lau, D. H. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.01.025 · Cited by 67
Zhang, F., Li, X., Ochs, T., Chen, L., Liao, Y., Tang, C., Jin, H., & Du, J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.025 · Cited by 66
“(20) reported that treatment with midodrine hydrochloride decreased tachycardia, during HUT, in 20 POTS patients.”
BackgroundResultLow-dose propranolol and exercise capacity in postural tachycardia syndrome: A randomized study
Arnold, A. C., Okamoto, L. E., Diedrich, A., Paranjape, S. Y., Raj, S. R., Biaggioni, I., & Gamboa, A. (2013) · Neurology · doi:10.1212/wnl.0b013e318293e310 · Cited by 65
“At low doses, propranolol reduces standingHR and improves orthostatic symptoms.(8,10,11) In contrast, higher doses can more effectively control tachycardia, but do not improve quality of life or orthostatic symptoms.”
BackgroundPostural Tachycardia Syndrome in Children and Adolescents
Jarjour, I. T. (2013) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2013.01.001 · Cited by 65
Acetylcholinesterase Inhibition in Patients With Orthostatic Intolerance
Singer, W., Opfer-Gehrking, T. L., Nickander, K. K., Hines, S. M., & Low, P. A. (2006) · Journal of Clinical Neurophysiology · doi:10.1097/01.wnp.0000229946.01494.4c · Cited by 60
“Their efficacy varies among patients and is oftentimes unsatisfactory (Gordon et al., 2000; Low et al., 1995; Low et al., 1994; Low et al., 1997; Sandroni et al., 1999).”
BackgroundSelf-citationTreatment of postural tachycardia syndrome: a comparison of octreotide and midodrine
Hoeldtke, R. D., Bryner, K. D., Hoeldtke, M. E., & Hobbs, G. (2006) · Clinical Autonomic Research · doi:10.1007/s10286-006-0373-0 · Cited by 57
“Midodrine, a dihydroergotamine like alpha 1 agonist and vasoconstrictor is often used to treat these disorders and its efficacy in POTS has been documented [3].”
BackgroundRuzieh, M., Baugh, A., Dasa, O., Parker, R. L., Perrault, J. T., Renno, A., Karabin, B. L., & Grubb, B. (2017) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-017-0225-y · Cited by 48
Yang, J., Zhao, J., Du, S., Liu, D., Fu, C., Li, X., Chen, S., Tang, C., Du, J., & Jin, H. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.04.039 · Cited by 47
“In 2000, Gordon et al discovered that treatment with midodrine hydrochloride decreased tachycardia on HUT in patients with POTS.(24) In 2006, Hoeldtke et al reported that after taking midodrine hydrochloride for 1 hour, the tachycardia in patients with POTS could be suppressed during HUT.”
BackgroundInfluentialZhao, J., Du, S., Yang, J., Lin, J., Tang, C., Du, J., & Jin, H. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.05.039 · Cited by 41
Liao, Y., Yang, J., Zhang, F., Chen, S., Liu, X., Zhang, Q., Ai, Y., Wang, Y., Tang, C., Du, J., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.05.008 · Cited by 39
Bruce, B. K., Harrison, T. E., Bee, S. M., Luedtke, C. A., Porter, C.-B. J., Fischer, P. R., Hayes, S. E., Allman, D. A., Ale, C. M., & Weiss, K. E. (2016) · Clinical Pediatrics · doi:10.1177/0009922816638663 · Cited by 31
Acute volume loading and exercise capacity in postural tachycardia syndrome
Figueroa, R. A., Arnold, A. C., Nwazue, V. C., Okamoto, L. E., Paranjape, S. Y., Black, B. K., Diedrich, A., Robertson, D., Biaggioni, I., Raj, S. R., et al. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00367.2014 · Cited by 31
Evaluating and managing postural tachycardia syndrome
Lei, L. Y., Chew, D. S., Sheldon, R. S., & Raj, S. R. (2019) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.86a.18002 · Cited by 28
“51,52 Chronic saline infusions are not recommended for long-term care because of the risk of access complications and infection.”
BackgroundZhao, J., Tang, C., Jin, H., & Du, J. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.04.032 · Cited by 27
Clinical neurophysiology of postural tachycardia syndrome
Cutsforth‐Gregory, J. K., & Sandroni, P. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64142-7.00066-7 · Cited by 25
Eftekhari, H., Maddock, H. L., Pearce, G., Raza, S., Kavi, L., Lim, P. B., Osman, F., & Hayat, S. A. (2021) · Autonomic Neuroscience · doi:10.1016/j.autneu.2021.102808 · Cited by 19
Orthostatic Cognitive Dysfunction in Postural Tachycardia Syndrome After Rapid Water Drinking
Rodriguez, B., Zimmermann, R., Gutbrod, K., Heinemann, D., & Z'Graggen, W. J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00327 · Cited by 19
“, 2010) or administration of 1,000 ml IV saline within approximately 60 min (Gordon et al., 2000).”
BackgroundPostural Orthostatic Tachycardia Syndrome (POTS)
Mizumaki, K. (2011) · Journal of Arrhythmia · doi:10.1016/s1880-4276(11)80031-1 · Cited by 19
Ghazal, M., Akkawi, A. R., Fancher, A. J., Oundo, E., Tanzeem, H., Sajjad, L., & Briasoulis, Α. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102977 · Cited by 20
Snapper, H., & Cheshire, W. P. (2022) · Autonomic Neuroscience · doi:10.1016/j.autneu.2022.102951 · Cited by 20
“The difference in heart rate change did not reach significance at the immediate or 5-min time points, and longer durations of tilt were not assessed (Gordon et al., 2005).”
Postural orthostatic tachycardia syndrome (POTS)
Sidhu, B., Obiechina, N., Rattu, N., & Mitra, S. (2013) · BMJ Case Reports · doi:10.1136/bcr-2013-201244 · Cited by 15
von Alvensleben, J. C. (2020) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2020.05.004 · Cited by 14
Chaudhari, S. A., Sacerdote, A. S., & Bahtiyar, G. (2012) · BMJ Case Reports · doi:10.1136/bcr.02.2012.5730 · Cited by 14
Systematic literature review: treatment of postural orthostatic tachycardia syndrome (POTS)
Schiweck, N., Langer, K., Maier, A., Vilser, D., & Spiegler, J. (2025) · Clinical Autonomic Research · doi:10.1007/s10286-025-01172-2 · Cited by 14
“Three non-RCTs investigated the effect of short-term [26, 27] and long-term, intermittent application of intravenous saline [28].”
InfluentialRodriguez, B., Hochstrasser, A., Eugster, P. J., Grouzmann, E., Müri, R. M., & Z'Graggen, W. J. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.968725 · Cited by 13
“Both results confirm previous findings of the beneficial effect of water drinking on orthostatic tachycardia and symptoms of orthostatic intolerance (Jacob et al., 1997; Gordon et al., 2000; Z’Graggen et al., 2010; Rodriguez et al., 2019; Snapper and Cheshire, 2022).”
ResultBohora, S. (2010) · PubMed Central · Cited by 17
Recognizing postural orthostatic tachycardia syndrome
Pavlik, D., Agnew, D. M., Stiles, L. E., & Ditoro, R. (2016) · JAAPA · doi:10.1097/01.jaa.0000481398.76099.09 · Cited by 11
Postural Tachycardia Syndrome (POTS)
Low, P. A., & Sandroni, P. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-386525-0.00106-2 · Cited by 15
Self-citationPostural Tachycardia Syndrome: Diagnosis and Management in Adolescents and Young Adults
Heyer, G. L. (2017) · Pediatric Annals · doi:10.3928/19382359-20170322-01 · Cited by 10
Bruce, B. K., Weiss, K., Harrison, T. E., Allman, D. A., Petersen, M. A., Luedkte, C. A., & Fischer, P. R. (2015) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-015-9438-3 · Cited by 10
Non-Pharmacological and Pharmacological Management of Cardiac Dysautonomia Syndromes
Lakkireddy, D. (2019) · Journal of Atrial Fibrillation · doi:10.4022/jafib.2395 · Cited by 7
Freeman, R. L., & Kaufmann, H. (2007) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000299966.05395.6c · Cited by 7
“…of orthostatic tolerance with pharmacologic agents that include IV saline (Jacob et al, 1997b), IV phenylephrine (Stewart et al, 2002), midodrine (Gordon et al, 2000; Hoeldtke et al, 2006; Jacob et al, 1997b), octreotide (Hoeldtke et al, 2006), erythropoietin (Hoeldtke et al, 1995),…”
BackgroundLe syndrome de tachycardie posturale (PoTS) : une maladie pour l’interniste
Astudillo, L. M., Laure, A., Fabry, V., Pugnet, G., Maury, P., Labrunée, M., Sailler, L., & Traon, A. P. (2018) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2018.04.017 · Cited by 6
Two types of orthostatic dysregulation assessed by diameter of inferior vena cava
Fujii, Y., Ishizaki, Y., Kino, M., Taniuchi, S., Kobayashi, Y., & Kaneko, K. (2010) · Pediatrics International · doi:10.1111/j.1442-200x.2010.03228.x · Cited by 5
Short-term efficacy of ORS formulation and propranolol regimen in children with POTS
Yozgat, Y., Temur, H. O., Çoban, Ş., Öner, T., Karaarslan, U., Yozgat, C. Y., Karadeniz, C., Ergör, S. N., & Erenberk, U. (2020) · Archives de Pédiatrie · doi:10.1016/j.arcped.2020.06.001 · Cited by 5
Pathophysiology and Classification of PoTS
Lloyd, M. G., & Raj, S. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-54165-1_5 · Cited by 7
Using Clonidine for neuromodulation in patients with postural orthostatic tachycardia syndrome
Lin, S., Kote, A., Andersson, T., Goldhaber, J. I., Tisdale, J. E., Li, X., Chen, P., & Liu, X. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.05.003 · Cited by 2
Sjögren, P., Huhmar, H., Bertilson, B. C., Bragée, B., & Polo, O. J. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1601599 · Cited by 2
Postural Orthostatic Tachycardia Syndrome (POTS): A Review
Chung, T., & Raj, S. R. (2026) · JAMA · doi:10.1001/jama.2026.14809 · Cited by 2
Non-pharmacological Management (Hydration, Diet and Compression)
Eftekhari, H., & Bruce, D. (2020) · Springer eBooks · doi:10.1007/978-3-030-54165-1_25 · Cited by 2
Color M-Mode Mitral Propagation Velocity in Patients with Mitral Stenosis
Sarı, M. (2016) · Journal of Human Rhythm · Cited by 1
Gall, N. P. (2020) · Springer eBooks · doi:10.1007/978-3-030-54165-1_28 · Cited by 1
Neuropathic Postural Tachycardia Syndrome
Low, P. A. (2004) · Elsevier eBooks · doi:10.1016/b978-012589762-4/50093-1 · Cited by 1
Self-citationDesmopressin in the postural tachycardia syndrome
Weinstock, J. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.05.018 · Cited by 1
OBSOLETE: Sinus Tachycardias: Inappropriate Sinus Tachycardia and Postural Tachycardia Syndrome
Raj, S. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99799-x
Tupe, R. E., Landge, D., Rasve, V., & Pawar, J. B. (2021) · IJCRT - International Journal of Creative Research Thoughts (IJCRT)
Yanagimoto, Y., Ishizaki, Y., Nakai, Y., Minami, M., Tamai, R., Inoue, K., Masuda, N., & Kaneko, K. (2022) · Research Square · doi:10.21203/rs.3.rs-1208086/v1
Sinus Tachycardias: Inappropriate Sinus Tachycardia and Postural Tachycardia Syndrome
Shaw, B. H., Ng, J., & Raj, S. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99799-0
Gomes, J. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-45066-3_30
Benito, K., Ramanathan, A., Lobato, D. J., Jandasek, B. N., Mamaril, E., McBride, H., & Feit, L. R. (2022) · Children s Health Care · doi:10.1080/02739615.2022.2047049
“, 2014), and some mixed support for beta-blockers and alpha agonists (Gordon et al., 2000).”
BackgroundSinus Tachycardias: Inappropriate Sinus Tachycardia and Postural Orthostatic Tachycardia Syndrome
Talati, A., Uppal, J., Sheldon, R. S., & Raj, S. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00016-9
Kwok, C. S., Lee, S., Afzal, A., Choi, L., Nazari, B., Hall, M., Loke, Y. K., Qureshi, A. I., & Raj, S. R. (2026) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001822
Handy, A., Hira, R., Sheldon, R. S., & Raj, S. R. (2026) · Autonomic Neuroscience · doi:10.1016/j.autneu.2026.103480
Marchetta, M., Hogwood, A. C., Golino, M., Abbate, G., THOMAS, G. K., Markley, R., Stavrakis, S., Canada, J. M., & Abbate, A. (2026) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2026.10.007
Metadata
- Authors
- Gordon, V. M., Opfer-Gehrking, T. L., Novak, V., & Low, P. A.
- Corresponding author
- Low, Phillip A.
- Venue
- Clinical Autonomic Research
- Published
- 2000-02
- Volume
- 10
- Issue
- 1
- Pages
- 29-33
- ISSN
- 0959-9851 (ISSN-L)
- 1619-1560
- OpenAlex
- W2028493562
- Semantic Scholar
- 3e1713077d149f85f7aa867aa26a3cf896015e3c
- Cited by
- 69
- References
- 15
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 5 · 2021: 2 · 2020: 7 · 2019: 4 · 2018: 4 · 2017: 5 · 2016: 3 · 2015: 2 · 2014: 3 · 2013: 7 · 2012: 4
- FWCI
- 0.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Clinical Autonomic Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Aeronautics and Space Administration
- National Institutes of Health (1p01ns032352-01a1)
- National Institute of Neurological Disorders and Stroke (P01 NS 32352)
- National Center for Research Resources (M01-RR00 585, M01RR000585)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Keywords
- postural orthostatic tachycardia syndrome, head-up tilt, midodrine, propranolol, clonidine, phenobarbital, intravenous saline, volume expansion, heart rate response, blood pressure response, autonomic dysfunction, venous pooling, symptom scores
- MeSH terms
- Adolescent, Adult, Anti-Arrhythmia Agents, Antihypertensive Agents, Clonidine, Female, Hemodynamics, Humans, Male, Midodrine, Plasma Substitutes, Posture, Propranolol, Sodium Chloride, Syndrome, Tachycardia, Time Factors, Tilt-Table Test
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.